Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Amgen 10.054, Structure Therapeutics 0.
Amgen vs Structure Therapeutics: Revenue Comparison
Amgen (AMGN) and Structure Therapeutics (GPCR) are peers in GLP-1. Amgen reported revenue of $10.1B as of Q2 2026, compared with $0 for Structure Therapeutics. Amgen leads on revenue.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Amgen, Structure Therapeutics.| Metric | Amgen | Structure Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.05B | $0 |
| Cost of Revenue | $2.81B | $0 |
| Gross Profit | $7.24B | $0 |
| Operating Income | $3.51B | $-119.00M |
| Net Income | $2.38B | $-106.00M |
| R&D Expense | $1.87B | $100.00M |
| Earnings Per Share | $4.37 | -$1.47 |
| Gross Margin | 72.0% | - |
| Operating Margin | 35.0% | - |
| Net Profit Margin | 23.6% | - |
| Free Cash Flow | $3.49B | $-120.00M |
| Cumulative Free Cash Flow | $169.18B | $-589.00M |
| Operating Cash Flow | $4.00B | $-120.00M |
| Cash & Equivalents | $13.99B | $273.00M |